nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.0793	0.0793	CcSEcCtD
Pomalidomide—Night sweats—Varenicline—nicotine dependence	0.057	0.057	CcSEcCtD
Pomalidomide—Platelet count decreased—Varenicline—nicotine dependence	0.0517	0.0517	CcSEcCtD
Pomalidomide—Musculoskeletal pain—Varenicline—nicotine dependence	0.0311	0.0311	CcSEcCtD
Pomalidomide—Pulmonary embolism—Varenicline—nicotine dependence	0.0308	0.0308	CcSEcCtD
Pomalidomide—Hyperkalaemia—Varenicline—nicotine dependence	0.0302	0.0302	CcSEcCtD
Pomalidomide—Atrial fibrillation—Varenicline—nicotine dependence	0.0236	0.0236	CcSEcCtD
Pomalidomide—Urinary retention—Varenicline—nicotine dependence	0.0212	0.0212	CcSEcCtD
Pomalidomide—Dry skin—Varenicline—nicotine dependence	0.0205	0.0205	CcSEcCtD
Pomalidomide—Hypokalaemia—Varenicline—nicotine dependence	0.0203	0.0203	CcSEcCtD
Pomalidomide—Breast disorder—Varenicline—nicotine dependence	0.0202	0.0202	CcSEcCtD
Pomalidomide—Nasopharyngitis—Varenicline—nicotine dependence	0.02	0.02	CcSEcCtD
Pomalidomide—Bronchitis—Varenicline—nicotine dependence	0.0186	0.0186	CcSEcCtD
Pomalidomide—Weight increased—Varenicline—nicotine dependence	0.0176	0.0176	CcSEcCtD
Pomalidomide—Hyperglycaemia—Varenicline—nicotine dependence	0.0174	0.0174	CcSEcCtD
Pomalidomide—Infestation NOS—Varenicline—nicotine dependence	0.0172	0.0172	CcSEcCtD
Pomalidomide—Infestation—Varenicline—nicotine dependence	0.0172	0.0172	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Varenicline—nicotine dependence	0.0163	0.0163	CcSEcCtD
Pomalidomide—Epistaxis—Varenicline—nicotine dependence	0.0162	0.0162	CcSEcCtD
Pomalidomide—Urinary tract disorder—Varenicline—nicotine dependence	0.0153	0.0153	CcSEcCtD
Pomalidomide—Oedema peripheral—Varenicline—nicotine dependence	0.0152	0.0152	CcSEcCtD
Pomalidomide—Connective tissue disorder—Varenicline—nicotine dependence	0.0152	0.0152	CcSEcCtD
Pomalidomide—Urethral disorder—Varenicline—nicotine dependence	0.0151	0.0151	CcSEcCtD
Pomalidomide—Cardiac disorder—Varenicline—nicotine dependence	0.0143	0.0143	CcSEcCtD
Pomalidomide—Angiopathy—Varenicline—nicotine dependence	0.014	0.014	CcSEcCtD
Pomalidomide—Mediastinal disorder—Varenicline—nicotine dependence	0.0139	0.0139	CcSEcCtD
Pomalidomide—Chills—Varenicline—nicotine dependence	0.0139	0.0139	CcSEcCtD
Pomalidomide—Mental disorder—Varenicline—nicotine dependence	0.0135	0.0135	CcSEcCtD
Pomalidomide—Malnutrition—Varenicline—nicotine dependence	0.0134	0.0134	CcSEcCtD
Pomalidomide—Back pain—Varenicline—nicotine dependence	0.013	0.013	CcSEcCtD
Pomalidomide—Muscle spasms—Varenicline—nicotine dependence	0.0129	0.0129	CcSEcCtD
Pomalidomide—Tremor—Varenicline—nicotine dependence	0.0126	0.0126	CcSEcCtD
Pomalidomide—Anaemia—Varenicline—nicotine dependence	0.0124	0.0124	CcSEcCtD
Pomalidomide—Vertigo—Varenicline—nicotine dependence	0.0121	0.0121	CcSEcCtD
Pomalidomide—Cough—Varenicline—nicotine dependence	0.0117	0.0117	CcSEcCtD
Pomalidomide—Arthralgia—Varenicline—nicotine dependence	0.0114	0.0114	CcSEcCtD
Pomalidomide—Anxiety—Varenicline—nicotine dependence	0.0114	0.0114	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0114	0.0114	CcSEcCtD
Pomalidomide—Infection—Varenicline—nicotine dependence	0.0109	0.0109	CcSEcCtD
Pomalidomide—Nervous system disorder—Varenicline—nicotine dependence	0.0108	0.0108	CcSEcCtD
Pomalidomide—Thrombocytopenia—Varenicline—nicotine dependence	0.0107	0.0107	CcSEcCtD
Pomalidomide—Skin disorder—Varenicline—nicotine dependence	0.0107	0.0107	CcSEcCtD
Pomalidomide—Hyperhidrosis—Varenicline—nicotine dependence	0.0106	0.0106	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.01	0.01	CcSEcCtD
Pomalidomide—Insomnia—Varenicline—nicotine dependence	0.00992	0.00992	CcSEcCtD
Pomalidomide—Dyspnoea—Varenicline—nicotine dependence	0.00978	0.00978	CcSEcCtD
Pomalidomide—Decreased appetite—Varenicline—nicotine dependence	0.00954	0.00954	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00947	0.00947	CcSEcCtD
Pomalidomide—Fatigue—Varenicline—nicotine dependence	0.00946	0.00946	CcSEcCtD
Pomalidomide—Pain—Varenicline—nicotine dependence	0.00938	0.00938	CcSEcCtD
Pomalidomide—Constipation—Varenicline—nicotine dependence	0.00938	0.00938	CcSEcCtD
Pomalidomide—Feeling abnormal—Varenicline—nicotine dependence	0.00904	0.00904	CcSEcCtD
Pomalidomide—Body temperature increased—Varenicline—nicotine dependence	0.00867	0.00867	CcSEcCtD
Pomalidomide—Hypersensitivity—Varenicline—nicotine dependence	0.00808	0.00808	CcSEcCtD
Pomalidomide—Asthenia—Varenicline—nicotine dependence	0.00787	0.00787	CcSEcCtD
Pomalidomide—Pruritus—Varenicline—nicotine dependence	0.00776	0.00776	CcSEcCtD
Pomalidomide—Diarrhoea—Varenicline—nicotine dependence	0.00751	0.00751	CcSEcCtD
Pomalidomide—Dizziness—Varenicline—nicotine dependence	0.00726	0.00726	CcSEcCtD
Pomalidomide—Vomiting—Varenicline—nicotine dependence	0.00698	0.00698	CcSEcCtD
Pomalidomide—Rash—Varenicline—nicotine dependence	0.00692	0.00692	CcSEcCtD
Pomalidomide—Dermatitis—Varenicline—nicotine dependence	0.00691	0.00691	CcSEcCtD
Pomalidomide—Headache—Varenicline—nicotine dependence	0.00687	0.00687	CcSEcCtD
Pomalidomide—Nausea—Varenicline—nicotine dependence	0.00652	0.00652	CcSEcCtD
